| 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial J Kropff, S Del Favero, J Place, C Toffanin, R Visentin, M Monaro, ... The lancet Diabetes & endocrinology 3 (12), 939-947, 2015 | 255 | 2015 |
| The UVA/Padova type 1 diabetes simulator goes from single meal to single day R Visentin, E Campos-Náñez, M Schiavon, D Lv, M Vettoretti, M Breton, ... Journal of diabetes science and technology 12 (2), 273-281, 2018 | 217 | 2018 |
| Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas BP Kovatchev, E Renard, C Cobelli, HC Zisser, P Keith-Hynes, ... Diabetes care 36 (7), 1851-1858, 2013 | 214 | 2013 |
| Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: results of a single-arm 1-month experience compared with a previously … E Renard, A Farret, J Kropff, D Bruttomesso, M Messori, J Place, ... Diabetes Care 39 (7), 1151-1160, 2016 | 123 | 2016 |
| First use of model predictive control in outpatient wearable artificial pancreas S Del Favero, D Bruttomesso, F Di Palma, G Lanzola, R Visentin, A Filippi, ... Diabetes care 37 (5), 1212-1215, 2014 | 118 | 2014 |
| Toward a run-to-run adaptive artificial pancreas: In silico results C Toffanin, R Visentin, M Messori, F Di Palma, L Magni, C Cobelli IEEE Transactions on Biomedical Engineering 65 (3), 479-488, 2017 | 116 | 2017 |
| Circadian variability of insulin sensitivity: physiological input for in silico artificial pancreas R Visentin, C Dalla Man, YC Kudva, A Basu, C Cobelli Diabetes technology & therapeutics 17 (1), 1-7, 2015 | 108 | 2015 |
| The university of Virginia/Padova type 1 diabetes simulator matches the glucose traces of a clinical trial R Visentin, C Dalla Man, B Kovatchev, C Cobelli Diabetes technology & therapeutics 16 (7), 428-434, 2014 | 106 | 2014 |
| Randomized summer camp crossover trial in 5-to 9-year-old children: outpatient wearable artificial pancreas is feasible and safe S Del Favero, F Boscari, M Messori, I Rabbone, R Bonfanti, A Sabbion, ... Diabetes Care 39 (7), 1180-1185, 2016 | 99 | 2016 |
| Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive … S Del Favero, J Place, J Kropff, M Messori, P Keith‐Hynes, R Visentin, ... Diabetes, Obesity and Metabolism 17 (5), 468-476, 2015 | 96 | 2015 |
| Randomized controlled trial of a MUFA or fiber-rich diet on hepatic fat in prediabetes I Errazuriz, S Dube, M Slama, R Visentin, S Nayar, H O’Connor, C Cobelli, ... The Journal of Clinical Endocrinology & Metabolism 102 (5), 1765-1774, 2017 | 85 | 2017 |
| One-day Bayesian cloning of type 1 diabetes subjects: toward a single-day UVA/Padova type 1 diabetes simulator R Visentin, C Dalla Man, C Cobelli IEEE Transactions on Biomedical Engineering 63 (11), 2416-2424, 2016 | 79 | 2016 |
| Multinight “bedside” closed-loop control for patients with type 1 diabetes SA Brown, BP Kovatchev, MD Breton, SM Anderson, P Keith-Hynes, ... Diabetes technology & therapeutics 17 (3), 203-209, 2015 | 74 | 2015 |
| Personalized blood glucose prediction: A hybrid approach using grammatical evolution and physiological models I Contreras, S Oviedo, M Vettoretti, R Visentin, J Vehí PloS one 12 (11), e0187754, 2017 | 73 | 2017 |
| Individually adaptive artificial pancreas in subjects with type 1 diabetes: a one-month proof-of-concept trial in free-living conditions M Messori, J Kropff, S Del Favero, J Place, R Visentin, R Calore, ... Diabetes Technology & Therapeutics 19 (10), 560-571, 2017 | 66 | 2017 |
| Evaluating the experience of children with type 1 diabetes and their parents taking part in an artificial pancreas clinical trial over multiple days in a diabetes camp setting A Troncone, R Bonfanti, D Iafusco, I Rabbone, A Sabbion, R Schiaffini, ... Diabetes Care 39 (12), 2158-2164, 2016 | 37 | 2016 |
| Accuracy of a CGM sensor in pediatric subjects with type 1 diabetes. Comparison of three insertion sites: arm, abdomen, and gluteus S Faccioli, S Del Favero, R Visentin, R Bonfanti, D Iafusco, I Rabbone, ... Journal of diabetes science and technology 11 (6), 1147-1154, 2017 | 36 | 2017 |
| Dual glucagon‐like peptide‐1 receptor/glucagon receptor agonist SAR425899 improves beta‐cell function in type 2 diabetes R Visentin, M Schiavon, B Göbel, M Riz, C Cobelli, T Klabunde, ... Diabetes, Obesity and Metabolism 22 (4), 640-647, 2020 | 35 | 2020 |
| Improving efficacy of inhaled technosphere insulin (Afrezza) by postmeal dosing: in-silico clinical trial with the University of Virginia/Padova type 1 diabetes simulator R Visentin, C Giegerich, R Jäger, R Dahmen, A Boss, M Grant, ... Diabetes technology & therapeutics 18 (9), 574-585, 2016 | 35 | 2016 |
| Overnight closed-loop control improves glycemic control in a multicenter study of adults with type 1 diabetes SA Brown, MD Breton, SM Anderson, L Kollar, P Keith-Hynes, CJ Levy, ... The Journal of Clinical Endocrinology & Metabolism 102 (10), 3674-3682, 2017 | 28 | 2017 |
Claudio CobelliFull Professor of Bioengineering, University of PadovaEmail verificata su dei.unipd.it
